Study of TBI-1301 (NY-ESO-1 Specific TCR Gene Transduced Autologous T Lymphocytes) in Patients With Solid Tumors
Last updated on July 2021Recruitment
- Recruitment Status
- Recruiting
- Estimated Enrollment
- 15
Summary
- Conditions
- Bladder Cancer
- Esophageal Cancer
- Liver Cancer
- Lung Cancer
- Melanoma
- NY-ESO-1 Expressing Solid Tumors in HLA-A2 Positive Patients
- Ovarian Cancer
- Synovial Sarcoma
- Type
- Interventional
- Phase
- Phase 1
- Design
- Allocation: Non-RandomizedIntervention Model: Single Group AssignmentMasking: None (Open Label)Primary Purpose: Treatment
Participation Requirements
- Age
- Between 16 years and 125 years
- Gender
- Both males and females
Description
Not Provided
Not Provided
Tracking Information
- NCT #
- NCT02869217
- Collaborators
- Takara Bio Inc.
- Investigators
- Not Provided